Journals / Retina-Vitreus / 2022 / Cilt: 31 - Sayı: 1

RNFL, GC-IPL and Choroidal Thickness in Non- Proliferative Diabetic Retinopathy

Pages
24–31
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The intricate relationship between neural and vascular structures requires additional insights to understand the initiation of DR.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To assess retinal nerve fiber layer (RNFL), ganglion cell-inner plexiform layer (GC-IPL) and subfoveal choroidal thickness (SCT) using spectral-domain optical coherence tomography (SD-OCT) in treatment-naive diabetes mellitus (DM) patients and compare the results according to diabetic retinopathy (DR) severity, DM duration and HbA1c levels Methods: Two hundred and seventy four eyes 144 DR treatment-naive DM patients were included.
📊
Key Findings & Data:Results: As we compared average GC-IPL thicknesses of patients with respect to DR stages; moderate non-proliferative diabetic retinopathy (NPDR) and no apparent DR groups showed statistically significant difference (p = 0,012); and also severe NPDR and no apparent DR groups showed statistically significant difference (p = 0,008).
💡
Conclusion & Impact:The intricate relationship between neural and vascular structures requires additional insights to understand the initiation of DR.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To assess retinal nerve fiber layer (RNFL), ganglion cell-inner plexiform layer (GC-IPL) and subfoveal choroidal thickness (SCT) using spectral-domain optical coherence tomography (SD-OCT) in treatment-naive diabetes mellitus (DM) patients and compare the results according to diabetic retinopathy (DR) severity, DM duration and HbA1c levels Methods: Two hundred and seventy four eyes 144 DR treatment-naive DM patients were included. Complete ophthalmic examination was performed in each patient by a single examiner. DR was graded according to the International Clinical Diabetic Retinopathy Disease Severity scale. OCT scans were performed by an experienced technician using Cirrus HD-OCT. Results: As we compared average GC-IPL thicknesses of patients with respect to DR stages; moderate non-proliferative diabetic retinopathy (NPDR) and no apparent DR groups showed statistically significant difference (p = 0,012); and also severe NPDR and no apparent DR groups showed statistically significant difference (p = 0,008). When we selected the patients with HbA1c≤7%; we have found statistically significant difference only between no DR and severe NPDR group (p=0,013).According to DR stages; we did not find any statistically significant differences in terms of RNFL and SCT. DM duration, HbA1C levels and medications used to control DM did not show any correlation with average RNFL and GC-IPL thicknesses. Conclusions: We found statistically significant differences in GC-IPL thicknesses but RNFL thicknesses were comparable across DR stages. Despite the absence of proliferative disease neuroretinal changes were evident in patients with good metabolic control (HbA1c≤7%). The intricate relationship between neural and vascular structures requires additional insights to understand the initiation of DR.

🔖

Cite This Article

Erkan, E., Dündar, S. (2022). RNFL, GC-IPL and Choroidal Thickness in Non- Proliferative Diabetic Retinopathy. Retina-Vitreus, Cilt: 31 - Sayı: 1, 24–31. https://ajindex.com/articles/589030

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010; 376:124-36
  2. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012; 366:1227-39
  3. A. R. Santos, L. Ribeiro, F. Bandello et al., Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross-sectional analyses of baseline data of the EUROCONDOR project, Diabetes, 2017, vol. 66, no. 9,pp. 2503-10,
  4. De Benedetto U, Querques G, Lattanzio R, Borrelli E, Triolo G, Maestranzi G et al. Macular dysfunction is common in bothtype 1 and type 2 diabetic patients without macular edema. Retina 2014; 34: 2171-7
  5. Bearse MA, Ozawa GY. Multifocal electroretinography in diabetic retinopathy and diabetic macular edema. CurrDiab Rep 2014; 14: 526
  6. Shahidi AM, Sampson GP, Pritchard N, et al. Retinal nerve fibre layer thinning associated with diabetic peripheral neuropathy. Diabet Med. 2012; 29:106-11
  7. Leung CK, Lam S, Weinreb RN, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: analysis of the retinal nerve fiber layer map for glaucoma detection. Ophthalmology. 2010; 117:1684-91
  8. Cabrera DeBuc D, Somfai GM. Early detection of retinal thickness changes in diabetes using optical coherence tomography. Med SciMonit 2010; 16: MT15-MT21
  9. Rodrigues EB, Urias MG, Penha FM, Badaró E, Novais E, Meirelles R, Farah ME. Diabetes induces changes in neuroretina before retinal vessels: a spectral-domain optical coherence tomography study. Int J Retina Vitreous. 2015 Apr 15; 1:4 10. Ohara Z, Tabuchi H, Nakakura S, Yoshizumi Y, Sumino H, Maeda Y, Kiuchi Y. Changes in choroidal thickness in patients with diabetic retinopathy. IntOphthalmol. 2018 Feb; 38(1):279- 286. doi: 10.1007/s10792-017-0459-9
  10. Spaide RF Koizumi H Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008; 146: 496-500 12. Margolis R Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009; 147: 811-5
  11. Wilkinson CP, Ferris FLIII, Klein RE, et al: Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110:1677- 82
  12. Simó R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. 2018; 61(9):1902-12 15. Gardner TW, Davila JR. The neurovascular unit and the pathophysiologic basis of diabetic re